Park J - Search Results

1

PD-1 Blockade Reinvigorates Bone Marrow CD8⁺ T Cells from Patients with Multiple Myeloma in the Presence of TGFβ Inhibitors.

Kwon M, Kim CG, Lee H, Cho H, Kim Y, Lee EC, Choi SJ, Park J, Seo IH, Bogen B, Song IC, Jo DY, Kim JS, Park SH, Choi I, Choi YS, Shin EC. Kwon M, et al. Among authors: park sh, park j. Clin Cancer Res. 2020 Apr 1;26(7):1644-1655. doi: 10.1158/1078-0432.CCR-19-0267. Epub 2020 Jan 15. Clin Cancer Res. 2020. PMID: 31941832

2

Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1-high T cells.

Kim JH, Choi YJ, Lee BH, Song MY, Ban CY, Kim J, Park J, Kim SE, Kim TG, Park SH, Kim HP, Sung YC, Kim SC, Shin EC. Kim JH, et al. Among authors: park sh, park j. J Allergy Clin Immunol. 2016 May;137(5):1466-1476.e3. doi: 10.1016/j.jaci.2015.11.021. Epub 2016 Jan 27. J Allergy Clin Immunol. 2016. PMID: 26824999

3

Immune checkpoint inhibitors for cancer treatment.

Park J, Kwon M, Shin EC. Park J, et al. Arch Pharm Res. 2016 Nov;39(11):1577-1587. doi: 10.1007/s12272-016-0850-5. Epub 2016 Oct 21. Arch Pharm Res. 2016. PMID: 27770382 Review.

4

Herpes Zoster DNA Vaccines with IL-7 and IL-33 Molecular Adjuvants Elicit Protective T Cell Immunity.

Kim AR, Park J, Kim JH, Kwak JE, Cho Y, Lee H, Jeong M, Park SH, Shin EC. Kim AR, et al. Among authors: park sh, park j. Immune Netw. 2018 Oct 31;18(5):e38. doi: 10.4110/in.2018.18.e38. eCollection 2018 Oct. Immune Netw. 2018. PMID: 30402333 Free PMC article.

5

Immune Checkpoint Inhibitor-induced Reinvigoration of Tumor-infiltrating CD8⁺ T Cells is Determined by Their Differentiation Status in Glioblastoma.

Park J, Kwon M, Kim KH, Kim TS, Hong SH, Kim CG, Kang SG, Moon JH, Kim EH, Park SH, Chang JH, Shin EC. Park J, et al. Among authors: park sh. Clin Cancer Res. 2019 Apr 15;25(8):2549-2559. doi: 10.1158/1078-0432.CCR-18-2564. Epub 2019 Jan 18. Clin Cancer Res. 2019. PMID: 30659023

6

Immunogenicity and safety of a new live attenuated herpes zoster vaccine (NBP608) compared to Zostavax® in healthy adults aged 50 years and older.

Choi WS, Choi JH, Jung DS, Choi HJ, Kim YS, Lee J, Jang HC, Shin EC, Park JS, Kim H, Cheong HJ. Choi WS, et al. Among authors: park js. Vaccine. 2019 Jun 12;37(27):3605-3610. doi: 10.1016/j.vaccine.2019.04.046. Epub 2019 May 20. Vaccine. 2019. PMID: 31122860 Clinical Trial.

7

Functions of human liver CD69⁺CD103^-CD8⁺ T cells depend on HIF-2α activity in healthy and pathologic livers.

Kim JH, Han JW, Choi YJ, Rha MS, Koh JY, Kim KH, Kim CG, Lee YJ, Kim AR, Park J, Kim HK, Min BS, Seo SI, Kang M, Park HJ, Han DH, Kim SI, Kim MS, Lee JG, Lee DH, Kim W, Park JY, Park SH, Joo DJ, Shin EC. Kim JH, et al. Among authors: park jy, park sh, park j, park hj. J Hepatol. 2020 Jun;72(6):1170-1181. doi: 10.1016/j.jhep.2020.01.010. Epub 2020 Jan 24. J Hepatol. 2020. PMID: 31987989

8

4-1BB co-stimulation further enhances anti-PD-1-mediated reinvigoration of exhausted CD39⁺ CD8 T cells from primary and metastatic sites of epithelial ovarian cancers.

Leem G, Park J, Jeon M, Kim ES, Kim SW, Lee YJ, Choi SJ, Choi B, Park S, Ju YS, Jung I, Kim S, Shin EC, Lee JY, Park SH. Leem G, et al. Among authors: park s, park sh, park j. J Immunother Cancer. 2020 Dec;8(2):e001650. doi: 10.1136/jitc-2020-001650. J Immunother Cancer. 2020. PMID: 33335029 Free PMC article.

9

Spatial immune heterogeneity of hypoxia-induced exhausted features in high-grade glioma.

Kim AR, Choi SJ, Park J, Kwon M, Chowdhury T, Yu HJ, Kim S, Kang H, Kim KM, Park SH, Park CK, Shin EC. Kim AR, et al. Among authors: park ck, park sh, park j. Oncoimmunology. 2022 Jan 12;11(1):2026019. doi: 10.1080/2162402X.2022.2026019. eCollection 2022. Oncoimmunology. 2022. PMID: 35036078 Free PMC article.

10

CEACAM1 Marks Highly Suppressive Intratumoral Regulatory T Cells for Targeted Depletion Therapy.

Jeon SH, Kang M, Jeon M, Chung Y, Kim AR, Lee YJ, Kim ES, Nam H, Park J, Lee JY, Shin EC, Seo SI, Park SH. Jeon SH, et al. Among authors: park sh, park j. Clin Cancer Res. 2023 May 1;29(9):1794-1806. doi: 10.1158/1078-0432.CCR-22-1843. Clin Cancer Res. 2023. PMID: 36716293

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68,570 results

Search Page